CTMX
CytomX Therapeutics Inc
2.60$
-2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -186.2% | – | – | -144.3% | – | – | -2,363.4% | – | – | – | – | |
| – | +54.0% | +43.7% | -5.1% | +14.5% | +38.3% | -1.2% | +5.2% | -9.7% | -11.0% | -18.7% | -22.2% | |
| – | +620.8% | +153.3% | +11.8% | +49.5% | +13.2% | -22.6% | -10.9% | -0.3% | -34.8% | -10.4% | -17.8% | |
| – | +1,023.5% | +71.6% | +84.0% | -22.7% | +22.7% | -28.6% | -10.9% | +0.0% | – | – | – | |
| – | -100.4% | – | +339.1% | -104.2% | – | – | -401.6% | – | – | – | – | |
| – | -4.1% | +36.5% | -28.4% | +143.0% | -7.7% | -34.0% | -30.3% | +8.1% | -51.7% | -63.1% | -29.0% | |
| – | +7,751.0% | – | -364.4% | – | +1,244.9% | -123.5% | – | +336.9% | -253.3% | – | -159.9% | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +83,712.5% | -86.1% | +2,458.7% | +486.8% | -98.8% | +938.3% | +552.4% | +0.0% | – | – | – | |
| – | +144.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +500.3% | -99.4% | +2,289.2% | +486.8% | -98.8% | +938.3% | +552.4% | -99.4% | +4,565.1% | -75.1% | +1,368.3% | |
| – | -108.2% | – | +62.6% | -3.9% | -184.5% | – | +298.1% | -186.9% | – | – | -218.6% | |
| – | -196.3% | – | – | -147.0% | – | – | -4,189.5% | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.